UAE approves late stage trial of Jiangsu's COVID-19 vaccine

China |  News | 0 Comment | 13 Apr, 2022

China's Jiangsu Recbio Technology has received approval from the Ministry of Health and Prevention of the United Arab Em...Read more

BRV China-backed exoskeleton startup RoboCT secures RMB100 million

China |  News | 0 Comment | 13 Apr, 2022

Hangzhou RoboCT Technology Development Co., Ltd., a global leading exoskeleton company, recently completed RMB100 millio...Read more

VenusP-Valve obtains CE marking under MDR and debuts in Europe as China's first valve product

China |  News | 0 Comment | 12 Apr, 2022

VenusP-Valve, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, rece...Read more

Hong Kong discovers distinct gut microbial signatures for 'long COVID'

China |  News | 0 Comment | 11 Apr, 2022

Clinical researchers from The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) have identified...Read more

Biocytogen signs RenMab/RenLite licensing agreement with BeiGene

China |  News | 0 Comment | 11 Apr, 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. have reached an agreement with BeiGene (Beijing) for licensing of Biocyto...Read more

CARsgen appoints Dr Raffaele Baffa as Chief Medical Officer

China |  News | 0 Comment | 08 Apr, 2022

China's CARsgen Therapeutics Holdings, a company focused on innovative CAR T cell therapies for the treatment of hematol...Read more

SeekIn receives CE Mark approval for LeukoPrint molecular karyotyping test

China |  News | 0 Comment | 08 Apr, 2022

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...Read more

Chinese firms strengthen focus on development and commercialisation of mRNA vaccines

China |  News | 0 Comment | 07 Apr, 2022

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...Read more

Rona Therapeutics raises $33 million in Series A

China |  News | 0 Comment | 07 Apr, 2022

China-based startup Rona Therapeutics announces the successful completion of $33 million Series A financing to advance p...Read more

Everest Medicines announces positive results from Chinese subpopulation for NEFECON

China |  News | 0 Comment | 06 Apr, 2022

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical ...Read more

Hong Kong highlights significant global incidence of newly diagnosed type 1 diabetes

China |  News | 0 Comment | 06 Apr, 2022

One of the largest global studies of its kind, led by The Chinese University of Hong Kong (CUHK)’s Faculty of Medi...Read more

Ascletis seeks authorization for Ritonavir in Hong Kong

China |  News | 0 Comment | 04 Apr, 2022

Ascletis Pharma has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the H...Read more

China approves clinical trial for CanSinoBIO's COVID-19 mRNA vaccine

China |  News | 0 Comment | 05 Apr, 2022

CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...Read more

China backs 'Tai Chi Training' to improve Parkinson's Disease and mild cognitive impairment

China |  News | 0 Comment | 01 Apr, 2022

The latest research shows that Tai Chi training (an internal Chinese martial art) is conducive to the treatment of Parki...Read more

Zhimeng Biopharma begins Phase I trial of Hep B drug

China |  News | 0 Comment | 01 Apr, 2022

China's Zhimeng Biopharma, Inc., an innovation-driven biopharmaceutical company focused on the development of innovative...Read more

UMP Healthcare expands free telemedicine and drug delivery to COVID-19 patients

China |  News | 0 Comment | 01 Apr, 2022

Hong Kong based UMP Healthcare Holdings Limited has announced the results of a recent service survey, which found that a...Read more

JW Therapeutics announces IND approval of Carteyva

China |  News | 0 Comment | 31 Mar, 2022

China's JW Therapeutics has received the Investigational New Drug (IND) clearance from the National Medical Products Adm...Read more

CStone starts phase I trial of cancer drug

China |  News | 0 Comment | 31 Mar, 2022

China's CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercial...Read more